Eli Lilly
IRS: 350470950LLY
Eli Lilly is a drug company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiantfor immunology.
Founded
1901 (120 years)
Revenue
25 billion (2020)